Work

Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma

Year: 2011

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-011-9765-7

Authors: Jason Konner, Rachel N. Grisham, Jae Park, Owen A. O’Connor, Gillian Cropp, Robert Johnson, Alison L. Hannah, Martee L. Hensley, Paul Sabbatini, Svetlana Miranov, Samuel Danishefsky, David Hyman, David R. Spriggs, Jakob Dupont, Carol Aghajanian

Institutions: Memorial Sloan Kettering Cancer Center, New York University, Genentech

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G2169648687, G6995731259

OpenAlex ID: W2113578719

FWCI: 0.413

Cites: 49

Cited by: 12

Related to: 10